Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche awaits positive news from EPO (European Patent Office) on PCR (polymerase chain reaction) patents

This article was originally published in Clinica

Executive Summary

Roche says it has moved forward in its years-old battle to secure rights to its polymerase chain reaction (PCR) patents in various markets. Its two foundational patents have been subject to challenges in the US, and in Europe, where last week the European Patent Office's board of appeals signalled to Roche its intention to maintain the '184 and '362 patents, against a consortium of cross-industry companies from the healthcare and agriculture industries that had launched an opposition to the patents in 1995.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts